Working… Menu

A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01379274
Recruitment Status : Terminated (Loss of funding.)
First Posted : June 23, 2011
Last Update Posted : November 28, 2013
Celgene Corporation
Information provided by (Responsible Party):
Jamile Shammo, Rush University Medical Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2013
Actual Study Completion Date : November 2013